Leukemia inhibitory factor (LIF) is a cytokine encoded by the LIF gene. LIF is an IL-6 class protein that inhibits cell differentiation, affecting cell growth. A decrease in LIF levels signals the cells to differentiate. In developing embryos, trophectoderm expresses LIF. LIF binds to LIF-receptor (LIFR), present throughout the embryonic inner cell mass. During the blastocyst stage, the inner cell mass produces embryonic stem cells, and if we remove these cells from the inner cell mass, the embryo loses its LIF source.
LIF is produced as a 202 amino acid precursor protein. Upon removing 22 amino acids post-translationally, it processes the precursor protein into a 20 kilodalton active form. LIF is a stable and compact helix bundle composed of four helices, helix A, helix B, helix C, and helix D. LIF binds to its receptor LIFR and forms a heterodimer with the signal-transducing subunit GP130. GP130 is common to all LIFR receptor families. The heterodimer-complex formed activates the JAK/STAT and MAPK cascades, which in turn activates several pluripotency factors including Nanog, Sox-2, and Oct-4.
Some of the LIF aliases are LIF IL-6 6 Family Cytokine 2 3 5, Leukemia Inhibitory Factor 2 3 4, Hilda 2 3 4, Differentiation Inhibitory Activity 2 3, Cholinergic Differentiation Factor 2 3, Differentiation-Stimulating Factor 3 4.
NorthEast BioLab is by far the most responsive and thorough bioanalysis lab services CRO.
We partnered on several programs and found NorthEast BioLab responsive, collaborative, and reliable.
We trust NorthEast BioLab to design and execute the most streamlined and impactful bioanalytical projects.
We found their integrity as refreshing as readiness to provide creative scientific input and high-quality data.
We have worked with NorthEast BioLab for over ten years given their commitment to highest quality bioanalytical data.
NorthEast BioLab tremendously supported us in reproducing our critical lab discoveries for drug metabolism.
NorthEast BioLab always exceeds expectations on bioanalytical assay development, validation, and sample analysis.
NorthEast BioLab truly goes that extra mile, and we hope to continue enjoying seminal interactions with them.
NorthEast BioLab presents a science-based, hands-on, no-frills approach on the latest bioanalytical platforms.
We are thrilled to complete our bioanalytical studies with their top quality and incredibly responsive team.
We worked closely to implement the most efficient and cost-effective bioanalytical assay for our PK Studies.
Our projects with NorthEast BioLab include successful method development, validation, stability studies during Clinical Phase I – IV studies.
NorthEast BioLab provides critical insight, and are compliant with regulatory standards and industry best practices. We highly recommend them and look forward to working together again.
Our latest successful study was a pivotal bioequivalence study, where samples from a cross-over study with about 100 volunteers needed swift analysis.
This study, same as all other bioanalytical studies with NorthEast BioLab, was completed with top quality and reporting standard with incredible responsiveness.
As a small company, our vendors are key members of our project teams. The scientists at NorthEast BioLab are technical experts, who produce high-quality data, on-time, and on-budget.
The primary function of the Leukemia Inhibitory Factor is to induce terminal differentiation in myeloid leukemic cells. This terminal differentiation prevents the continued growth of leukemic cells. LIF can also promote cell differentiation and growth in different target cells and influence neural development, inflammation, cachexia, bone metabolism, and embryogenesis. Research has shown that p53-regulated Leukemia Inhibitory Factor can facilitate implantation i.e., embryo adhering to the uterus wall, in mouse models, and soon we can use them in humans. Studies also suggest recombinant human-LIF can help increase the implantation rate in unexplained infertility cases.
How long do you think it takes for a new drug to get approved in the US? About 12-15 years, that’s roughly 1/3rd duration of the entire professional career for any of us. Next, how much investment do you think is required to bring a new drug to market?
LIF testing detects its levels in the samples and helps us understand the function of the leukemia inhibitory factor. We at NorthEast BioLabs use MSD, Luminex, and ELISA assays to detect LIF cytokine in your samples. Below is a detailed ELISA protocol.
We begin LIF cytokine testing with a pre-coated antibody microplate, add 100 μl of sample or standard in each well, and incubate it for 2 hrs at 37℃. The antibody is specific to LIF, therefore any LIF present in the sample gets bound to the immobilized antibody. We then remove all the liquid from the wells, add 100 μl of biotin-conjugated antibody in each well, and incubate it for 1 hr at 37℃. We then wash the wells and incubate them with 100 μl Avidin-conjugated HRP for 1 hr at 37℃. To eliminate any unbounded reagent, we wash the wells, introduce 90 μl of TMB substrate solution, and incubate it for 15-30 mins at 37℃. The addition of TMB substrate solution results in color development in the well. Lastly, we add 50 μl of stop solution to end the reaction and measure the color intensity at 450 nm.
This sandwich-based, enzyme immunoassay technique has a detection range of 9.375 pg/ml – 600 pg/ml and can detect a minimum dose of 2.34 pg/ml LIF cytokine. The assay is highly precise with an inter-assay precision of < 10% and intra-assay precision of < 8%.
LIF cytokine is a pleiotropic cytokine that chiefly regulates the differentiation of leukemic cells. LIF can stimulate protein synthesis of acute-phase in hepatocytes, induce terminal differentiation in leukemic cells, and aid myeloid leukemia cells for hematopoietic differentiation. LIF is involved in kidney development and extracellular matrix repair. Research in transgenic mice with over-expressing-LIF showed that the mice developed mesangial proliferative glomerulonephritis. Researchers also introduce LIF to stem cell cultures for reducing spontaneous differentiation of the cells.
To learn more about leukemia inhibitory factor function, explore the resources below.
https://www.genecards.org/cgi-bin/carddisp.pl?gene=LIF
https://www.uniprot.org/uniprot/P15018
https://www.sigmaaldrich.com/life-science/stem-cell-biology/leukemia-inhibitory-factor-protein.html
https://pubmed.ncbi.nlm.nih.gov/10704254/
https://www.rcsb.org/pdb/gene/LIF
Brain-Derived Neurotrophic Factor
Granulate Colony Stimulation Factor
Epidermal growth factor
Fas Ligand
Granulocyte Macrophage Colony Stimulating Factor
Leukemia Inhibitory Factor
Luteinizing hormone
Macrophage Migration Inhibitory Factor
Interferon Beta
Interferon Gamma
Transforming Growth Factor Beta 1
B Type Natriuretic Peptide
Glial Fibrillary Acidic Protein
Cystatin C
Hepatocyte Growth Factor
Interferon Alpha 2
Tumor Necrosis Factor Alpha
